Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

193 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[ANMCO Position paper: Pulmonary circulation diseases and COVID-19].
Picariello C, Caravita S, Vatrano M, Enea I, Roncon L, De Tommasi E, Imbalzano E, Garascia A, Manes MT, Misuraca L, Urbinati S, Colivicchi F, Gulizia MM, Gabrielli D; a nome dell’Area Malattie del Circolo Polmonare ANMCO. Picariello C, et al. Among authors: imbalzano e. G Ital Cardiol (Rome). 2020 Aug;21(8):575-583. doi: 10.1714/3405.33888. G Ital Cardiol (Rome). 2020. PMID: 32686781 Review. Italian.
Effects of genistein aglycone in glucocorticoid induced osteoporosis: A randomized clinical trial in comparison with alendronate.
Squadrito F, Imbalzano E, Rottura M, Arcoraci V, Pallio G, Catalano A, Atteritano M, Irrera N, Mannino F, Squadrito G, Vaccaro M, Irrera P, Pirrotta I, Bitto A. Squadrito F, et al. Among authors: imbalzano e. Biomed Pharmacother. 2023 Jul;163:114821. doi: 10.1016/j.biopha.2023.114821. Epub 2023 May 9. Biomed Pharmacother. 2023. PMID: 37167726 Free article. Clinical Trial.
Gliflozins: From Antidiabetic Drugs to Cornerstone in Heart Failure Therapy-A Boost to Their Utilization and Multidisciplinary Approach in the Management of Heart Failure.
Pistelli L, Parisi F, Correale M, Cocuzza F, Campanella F, de Ferrari T, Crea P, De Sarro R, La Cognata O, Ceratti S, Recupero T, Ruocco G, Palazzuoli A, Imbalzano E, Dattilo G. Pistelli L, et al. Among authors: imbalzano e. J Clin Med. 2023 Jan 3;12(1):379. doi: 10.3390/jcm12010379. J Clin Med. 2023. PMID: 36615178 Free PMC article. Review.
Safety and Efficacy of Rivaroxaban as Extended-Phase Anticoagulation in Patients with Cancer and Venous Thromboembolism: A Preliminary Data Analysis from the Mac Project.
Bernardi E, Camporese G, Bortoluzzi C, Noventa F, Ceccato D, Tonello C, Vohong S, Campello E, Simion C, Imbalzano E, Di Micco P, Callegari E, Simioni P. Bernardi E, et al. Among authors: imbalzano e. Life (Basel). 2022 Oct 28;12(11):1725. doi: 10.3390/life12111725. Life (Basel). 2022. PMID: 36362880 Free PMC article.
Safety and Efficacy of Rivaroxaban for Extended-Phase Anticoagulation of Patients with Unprovoked or Recurrent Venous Thromboembolism: Real-Life Data from the MAC Project.
Bortoluzzi C, Bernardi E, Camporese G, Noventa F, Ceccato D, Tonello C, Vo Hong N, Campello E, Simion C, Imbalzano E, Di Micco P, Callegari E, Simioni P. Bortoluzzi C, et al. Among authors: imbalzano e. Life (Basel). 2022 Oct 20;12(10):1657. doi: 10.3390/life12101657. Life (Basel). 2022. PMID: 36295091 Free PMC article.
193 results